Related Experiment Videos
Activation of the alternative complement pathway by Fonsecaea pedrosoi
The Journal of Investigative Dermatology
|October 1, 1984
Summary
Fonsecaea pedrosoi activates the human complement system through the alternative pathway. This process generates C5a, a key inflammatory molecule, indicating a potential role in host immune responses.
Area of Science:
- Immunology
- Microbiology
- Complement System Biology
Background:
- Fonsecaea pedrosoi is a fungus implicated in human infections.
- The complement system is a crucial part of innate immunity.
- Understanding how pathogens interact with the complement system is vital for developing therapeutic strategies.
Purpose of the Study:
- To investigate the interaction between Fonsecaea pedrosoi and the human complement system.
- To determine the specific pathway of complement activation induced by F. pedrosoi.
- To assess the generation of complement anaphylatoxin C5a during this activation.
Main Methods:
- Human sera were incubated with Fonsecaea pedrosoi.
- Complement activation was assessed by measuring C3 conversion using immunoelectrophoresis.
- Generation of C5a was quantified using radioimmunoassay.
- Functional assays involved heat-inactivated serum, EDTA-chelated serum, and serum depleted of Factor B.
- Classical pathway activation was blocked using Mg++-EGTA.
Main Results:
- Incubation of human sera with F. pedrosoi resulted in C3 conversion and C5a generation.
- These effects were abolished in serum lacking complement activity (heat-inactivated, EDTA-chelated) or deficient in Factor B.
- Complement activation occurred independently of the classical pathway, as demonstrated by Mg++-EGTA inhibition.
- F. pedrosoi specifically activates the alternative complement pathway.
Conclusions:
- Fonsecaea pedrosoi activates the human complement system predominantly via the alternative pathway.
- The activation results in the production of C5a, suggesting a role in inflammatory responses during F. pedrosoi infections.
- These findings contribute to understanding the immunobiology of chromoblastomycosis and related fungal diseases.